6472 — Bora Pharmaceuticals Co Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid CapHigh Flyer

Annual cashflow statement for Bora Pharmaceuticals Co, fiscal year end - December 31st, TWD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	325	595	1,024	1,840	4,064
Depreciation
Amortisation
Non-Cash Items	28.5	-337	70.6	197	1,269
Unusual Items
Other Non-Cash Items
Changes in Working Capital	-242	-221	-68.1	-352	-1,325
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	232	178	1,237	2,010	4,614
Capital Expenditures	-699	-152	-364	-193	-1,389
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	-129	-1,386	138	-4,088	-1,069
Acquisition of Business
Sale of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	-827	-1,538	-226	-4,281	-2,458
Financing Cash Flow Items	-11.7	-19	-54.3	472	-85.7
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	551	1,578	-741	4,595	-2,440
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	-44.9	217	241	2,371	-228